Also trades as: BIOG-B.ST (STO) · $vol 2M
BIOGY OTC
BioGaia AB (publ)
1W: +0.0%
1M: +0.0%
3M: +13.2%
YTD: +13.2%
1Y: +10.7%
3Y: +58.4%
5Y: +30.2%
$12.45
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$307M
-17.9% ▼
5Y CAGR: +6.7%
Capital Expenditures
$4M
+74.6% ▲
5Y CAGR: -25.9%
Free Cash Flow
$303M
-15.6% ▼
5Y CAGR: +8.1%
Dividends Paid
$698M
-0.2% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$423M
-32.0% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $254M | $361M | $443M | $423M | $412M |
| Depreciation & Amort. | $27M | $24M | $25M | $77M | $25M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$2M | -$5M | -$1M | -$50M | -$43M |
| Other Non-Cash Items | -$57M | -$62M | -$41M | -$77M | -$88M |
| Operating Cash Flow | $222M | $319M | $426M | $373M | $307M |
| — Investing Activities — | |||||
| Capital Expenditures | -$6M | -$18M | -$49M | -$14M | -$4M |
| Acquisitions (Net) | -$98M | $0 | $0 | $0 | $0 |
| Investment Purchases | -$22M | -$225K | -$2M | $0 | $0 |
| Investment Sales | $121M | $0 | $0 | $0 | $0 |
| Other Investing | -$121M | -$225K | -$146K | -$317K | $181K |
| Investing Cash Flow | -$127M | -$18M | -$51M | -$14M | -$3M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$7M | -$9M | -$11M | -$9M | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$69M | -$301M | -$293M | -$697M | -$698M |
| Other Financing | -$10M | -$3M | -$4M | -$4M | -$12M |
| Financing Cash Flow | -$82M | -$314M | -$308M | -$690M | -$710M |
| Net Change in Cash | $17M | $4M | $56M | -$320M | -$423M |
| Cash End of Period | $1.5B | $1.5B | $1.5B | $1.2B | $801M |
| Free Cash Flow | $215M | $301M | $377M | $359M | $303M |